<DOC>
	<DOCNO>NCT00161863</DOCNO>
	<brief_summary>The purpose study investigate safety five consecutive lot FSME-IMMUN NEW healthy volunteer . The main criterion investigation fever rate first vaccination three different age class . The immunogenicity 0.25 ml FSME-IMMUN NEW demonstrate previous clinical study child ; therefore , present study , immunogenicity investigate subgroup .</brief_summary>
	<brief_title>Safety Study FSME-IMMUN NEW Healthy Children Adolescents Aged 1 15 Years</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Tick-Borne</mesh_term>
	<criteria>Male female child adolescent eligible participation study : age 1 year ( 1st birthday ) &lt; 16 year ( last day 16th birthday ) ; clinically healthy , ( i. e. physician would reservations vaccinate FSMEIMMUN NEW outside scope clinical trial ) ; parents/legal guardian understand nature study agree provision ; write informed consent available parents/legal guardian , Germany/Austria : additional write informed consent available child older 8 year parents/legal guardian agree keep volunteer diary . For safety reason , female volunteer reach sexual maturity study start meet follow additional inclusion criterion : negative pregnancy test study entry ; Children adolescent exclude participation study : history TBE vaccination ; history TBE infection ; history allergic reaction one component vaccine ; suffer disease ( e.g . autoimmune disease ) undergo form treatment ( e.g . systemic corticosteroid , chemotherapeutics ) expect influence immunological function ; know HIV positive ( special HIV test require purpose study ) ; receive bank blood immunoglobulin within one month study entry ; history vaccination yellow fever and/or Japanese Bencephalitis ; suffer hemorrhagic diathesis ; participate simultaneously another clinical trial ; female : pregnant breastfeeding . Volunteers meet inclusion/exclusion criterion , febrile illness ( body temperature &gt; 38Â°C ) schedule time vaccination , vaccinate body temperature return normal . Volunteers receive vaccination within 4 week prior visit 1 vaccinate interval 4 week pass . In case visit 1 take place separately . If volunteer receive antipyretic within 4 hour prior intend TBE vaccination , vaccination perform late time . Volunteers positive TBE antibody value prior first vaccination exclude statistical analysis primary endpoint .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>